Table of Contents
Global Type 2 Diabetes Therapeutics Market Research Report 2021
1 Type 2 Diabetes Therapeutics Market Overview
1.1 Product Overview and Scope of Type 2 Diabetes Therapeutics
1.2 Type 2 Diabetes Therapeutics Segment by Type (Product Category)
1.2.1 Global Type 2 Diabetes Therapeutics Production and CAGR (%) Comparison by Type (Product Category)( 2016 - 2027)
1.2.2 Global Type 2 Diabetes Therapeutics Production Market Share by Type (Product Category) in 2020
1.2.3 DPP - 4 inhibitors
1.2.4 Biguanides
1.2.5 Insulins
1.2.6 GLP - 1 receptor agonists
1.2.7 Thiazolidenediones
1.2.8 Sulfonulureas
1.2.9 SGLT - 2 inhibitors
1.2.10 A - Glucosidase inhibitors
1.2.11 Others
1.3 Global Type 2 Diabetes Therapeutics Segment by Application
1.3.1 Type 2 Diabetes Therapeutics Consumption (Sales) Comparison by Application ( 2016 - 2027)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Global Type 2 Diabetes Therapeutics Market by Region ( 2016 - 2027)
1.4.1 Global Type 2 Diabetes Therapeutics Market Size (Value) and CAGR (%) Comparison by Region ( 2016 - 2027)
1.4.2 North America Status and Prospect ( 2016 - 2027)
1.4.3 Europe Status and Prospect ( 2016 - 2027)
1.4.4 China Status and Prospect ( 2016 - 2027)
1.4.5 Japan Status and Prospect ( 2016 - 2027)
1.4.6 Southeast Asia Status and Prospect ( 2016 - 2027)
1.4.7 India Status and Prospect ( 2016 - 2027)
1.5 Global Market Size (Value) of Type 2 Diabetes Therapeutics ( 2016 - 2027)
1.5.1 Global Type 2 Diabetes Therapeutics Revenue Status and Outlook ( 2016 - 2027)
1.5.2 Global Type 2 Diabetes Therapeutics Capacity, Production Status and Outlook ( 2016 - 2027)
2 Global Type 2 Diabetes Therapeutics Market Competition by Manufacturers
2.1 Global Type 2 Diabetes Therapeutics Capacity, Production and Share by Manufacturers ( 2016 - 2021)
2.1.1 Global Type 2 Diabetes Therapeutics Capacity and Share by Manufacturers ( 2016 - 2021)
2.1.2 Global Type 2 Diabetes Therapeutics Production and Share by Manufacturers ( 2016 - 2021)
2.2 Global Type 2 Diabetes Therapeutics Revenue and Share by Manufacturers ( 2016 - 2021)
2.3 Global Type 2 Diabetes Therapeutics Average Price by Manufacturers ( 2016 - 2021)
2.4 Manufacturers Type 2 Diabetes Therapeutics Manufacturing Base Distribution, Sales Area and Product Type
2.5 Type 2 Diabetes Therapeutics Market Competitive Situation and Trends
2.5.1 Type 2 Diabetes Therapeutics Market Concentration Rate
2.5.2 Type 2 Diabetes Therapeutics Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Type 2 Diabetes Therapeutics Capacity, Production, Revenue (Value) by Region ( 2016 - 2021)
3.1 Global Type 2 Diabetes Therapeutics Capacity and Market Share by Region ( 2016 - 2021)
3.2 Global Type 2 Diabetes Therapeutics Production and Market Share by Region ( 2016 - 2021)
3.3 Global Type 2 Diabetes Therapeutics Revenue (Value) and Market Share by Region ( 2016 - 2021)
3.4 Global Type 2 Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
3.5 North America Type 2 Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
3.6 Europe Type 2 Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
3.7 China Type 2 Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
3.8 Japan Type 2 Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
3.9 Southeast Asia Type 2 Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
3.10 India Type 2 Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
4 Global Type 2 Diabetes Therapeutics Supply (Production), Consumption, Export, Import by Region ( 2016 - 2021)
4.1 Global Type 2 Diabetes Therapeutics Consumption by Region ( 2016 - 2021)
4.2 North America Type 2 Diabetes Therapeutics Production, Consumption, Export, Import ( 2016 - 2021)
4.3 Europe Type 2 Diabetes Therapeutics Production, Consumption, Export, Import ( 2016 - 2021)
4.4 China Type 2 Diabetes Therapeutics Production, Consumption, Export, Import ( 2016 - 2021)
4.5 Japan Type 2 Diabetes Therapeutics Production, Consumption, Export, Import ( 2016 - 2021)
4.6 Southeast Asia Type 2 Diabetes Therapeutics Production, Consumption, Export, Import ( 2016 - 2021)
4.7 India Type 2 Diabetes Therapeutics Production, Consumption, Export, Import ( 2016 - 2021)
5 Global Type 2 Diabetes Therapeutics Production, Revenue (Value), Price Trend by Type
5.1 Global Type 2 Diabetes Therapeutics Production and Market Share by Type ( 2016 - 2021)
5.2 Global Type 2 Diabetes Therapeutics Revenue and Market Share by Type ( 2016 - 2021)
5.3 Global Type 2 Diabetes Therapeutics Price by Type ( 2016 - 2021)
5.4 Global Type 2 Diabetes Therapeutics Production Growth by Type ( 2016 - 2021)
6 Global Type 2 Diabetes Therapeutics Market Analysis by Application
6.1 Global Type 2 Diabetes Therapeutics Consumption and Market Share by Application ( 2016 - 2021)
6.2 Global Type 2 Diabetes Therapeutics Consumption Growth Rate by Application ( 2016 - 2021)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Type 2 Diabetes Therapeutics Manufacturers Profiles/Analysis
7.1 AstraZeneca
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Type 2 Diabetes Therapeutics Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 AstraZeneca Type 2 Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.1.4 Main Business/Business Overview
7.2 Novartis
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Type 2 Diabetes Therapeutics Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Novartis Type 2 Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.2.4 Main Business/Business Overview
7.3 Novo Nordisk
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Type 2 Diabetes Therapeutics Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Novo Nordisk Type 2 Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.3.4 Main Business/Business Overview
7.4 Boehringer Ingelheim
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Type 2 Diabetes Therapeutics Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Boehringer Ingelheim Type 2 Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.4.4 Main Business/Business Overview
7.5 Bristol - Myers Squibb
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Type 2 Diabetes Therapeutics Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Bristol - Myers Squibb Type 2 Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.5.4 Main Business/Business Overview
7.6 Eli Lilly
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Type 2 Diabetes Therapeutics Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Eli Lilly Type 2 Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.6.4 Main Business/Business Overview
7.7 Merck
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Type 2 Diabetes Therapeutics Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Merck Type 2 Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.7.4 Main Business/Business Overview
7.8 Sanofi
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Type 2 Diabetes Therapeutics Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Sanofi Type 2 Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.8.4 Main Business/Business Overview
7.9 Astellas Pharma
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Type 2 Diabetes Therapeutics Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Astellas Pharma Type 2 Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.9.4 Main Business/Business Overview
7.10 Daiichi Sankyo
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Type 2 Diabetes Therapeutics Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Daiichi Sankyo Type 2 Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.10.4 Main Business/Business Overview
7.11 Biocon
8 Type 2 Diabetes Therapeutics Manufacturing Cost Analysis
8.1 Type 2 Diabetes Therapeutics Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Type 2 Diabetes Therapeutics
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Type 2 Diabetes Therapeutics Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Type 2 Diabetes Therapeutics Major Manufacturers in 2020
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Type 2 Diabetes Therapeutics Market Forecast ( 2021 - 2027)
12.1 Global Type 2 Diabetes Therapeutics Capacity, Production, Revenue Forecast ( 2021 - 2027)
12.1.1 Global Type 2 Diabetes Therapeutics Capacity, Production and Growth Rate Forecast ( 2021 - 2027)
12.1.2 Global Type 2 Diabetes Therapeutics Revenue and Growth Rate Forecast ( 2021 - 2027)
12.1.3 Global Type 2 Diabetes Therapeutics Price and Trend Forecast ( 2021 - 2027)
12.2 Global Type 2 Diabetes Therapeutics Production, Consumption , Import and Export Forecast by Region ( 2021 - 2027)
12.2.1 North America Type 2 Diabetes Therapeutics Production, Revenue, Consumption, Export and Import Forecast ( 2021 - 2027)
12.2.2 Europe Type 2 Diabetes Therapeutics Production, Revenue, Consumption, Export and Import Forecast ( 2021 - 2027)
12.2.3 China Type 2 Diabetes Therapeutics Production, Revenue, Consumption, Export and Import Forecast ( 2021 - 2027)
12.2.4 Japan Type 2 Diabetes Therapeutics Production, Revenue, Consumption, Export and Import Forecast ( 2021 - 2027)
12.2.5 Southeast Asia Type 2 Diabetes Therapeutics Production, Revenue, Consumption, Export and Import Forecast ( 2021 - 2027)
12.2.6 India Type 2 Diabetes Therapeutics Production, Revenue, Consumption, Export and Import Forecast ( 2021 - 2027)
12.3 Global Type 2 Diabetes Therapeutics Production, Revenue and Price Forecast by Type ( 2021 - 2027)
12.4 Global Type 2 Diabetes Therapeutics Consumption Forecast by Application ( 2021 - 2027)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Type 2 Diabetes Therapeutics
Figure Global Type 2 Diabetes Therapeutics Production (K Units) and CAGR (%) Comparison by Types (Product Category) ( 2016 - 2027)
Figure Global Type 2 Diabetes Therapeutics Production Market Share by Types (Product Category) in 2020
Figure Product Picture of DPP - 4 inhibitors
Table Major Manufacturers of DPP - 4 inhibitors
Figure Product Picture of Biguanides
Table Major Manufacturers of Biguanides
Figure Product Picture of Insulins
Table Major Manufacturers of Insulins
Figure Product Picture of GLP - 1 receptor agonists
Table Major Manufacturers of GLP - 1 receptor agonists
Figure Product Picture of Thiazolidenediones
Table Major Manufacturers of Thiazolidenediones
Figure Product Picture of Sulfonulureas
Table Major Manufacturers of Sulfonulureas
Figure Product Picture of SGLT - 2 inhibitors
Table Major Manufacturers of SGLT - 2 inhibitors
Figure Product Picture of A - Glucosidase inhibitors
Table Major Manufacturers of A - Glucosidase inhibitors
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Type 2 Diabetes Therapeutics Consumption (K Units) by Applications ( 2016 - 2027)
Figure Global Type 2 Diabetes Therapeutics Consumption Market Share by Applications in 2020
Figure Hospital Pharmacy Examples
Table Key Downstream Customer in Hospital Pharmacy
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure Online Pharmacy Examples
Table Key Downstream Customer in Online Pharmacy
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Type 2 Diabetes Therapeutics Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions ( 2016 - 2027)
Figure North America Type 2 Diabetes Therapeutics Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Europe Type 2 Diabetes Therapeutics Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure China Type 2 Diabetes Therapeutics Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Japan Type 2 Diabetes Therapeutics Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Southeast Asia Type 2 Diabetes Therapeutics Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure India Type 2 Diabetes Therapeutics Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Global Type 2 Diabetes Therapeutics Revenue (Million USD) Status and Outlook ( 2016 - 2027)
Figure Global Type 2 Diabetes Therapeutics Capacity, Production (K Units) Status and Outlook ( 2016 - 2027)
Figure Global Type 2 Diabetes Therapeutics Major Players Product Capacity (K Units) ( 2016 - 2021)
Table Global Type 2 Diabetes Therapeutics Capacity (K Units) of Key Manufacturers ( 2016 - 2021)
Table Global Type 2 Diabetes Therapeutics Capacity Market Share of Key Manufacturers ( 2016 - 2021)
Figure Global Type 2 Diabetes Therapeutics Capacity (K Units) of Key Manufacturers in 2020
Figure Global Type 2 Diabetes Therapeutics Capacity (K Units) of Key Manufacturers in 2021
Figure Global Type 2 Diabetes Therapeutics Major Players Product Production (K Units) ( 2016 - 2021)
Table Global Type 2 Diabetes Therapeutics Production (K Units) of Key Manufacturers ( 2016 - 2021)
Table Global Type 2 Diabetes Therapeutics Production Share by Manufacturers ( 2016 - 2021)
Figure 2020 Type 2 Diabetes Therapeutics Production Share by Manufacturers
Figure 2020 Type 2 Diabetes Therapeutics Production Share by Manufacturers
Figure Global Type 2 Diabetes Therapeutics Major Players Product Revenue (Million USD) ( 2016 - 2021)
Table Global Type 2 Diabetes Therapeutics Revenue (Million USD) by Manufacturers ( 2016 - 2021)
Table Global Type 2 Diabetes Therapeutics Revenue Share by Manufacturers ( 2016 - 2021)
Table 2020 Global Type 2 Diabetes Therapeutics Revenue Share by Manufacturers
Table 2021 Global Type 2 Diabetes Therapeutics Revenue Share by Manufacturers
Table Global Market Type 2 Diabetes Therapeutics Average Price (USD/Unit) of Key Manufacturers ( 2016 - 2021)
Figure Global Market Type 2 Diabetes Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2020
Table Manufacturers Type 2 Diabetes Therapeutics Manufacturing Base Distribution and Sales Area
Table Manufacturers Type 2 Diabetes Therapeutics Product Category
Figure Type 2 Diabetes Therapeutics Market Share of Top 3 Manufacturers
Figure Type 2 Diabetes Therapeutics Market Share of Top 5 Manufacturers
Table Global Type 2 Diabetes Therapeutics Capacity (K Units) by Region ( 2016 - 2021)
Figure Global Type 2 Diabetes Therapeutics Capacity Market Share by Region ( 2016 - 2021)
Figure Global Type 2 Diabetes Therapeutics Capacity Market Share by Region ( 2016 - 2021)
Figure 2020 Global Type 2 Diabetes Therapeutics Capacity Market Share by Region
Table Global Type 2 Diabetes Therapeutics Production by Region ( 2016 - 2021)
Figure Global Type 2 Diabetes Therapeutics Production (K Units) by Region ( 2016 - 2021)
Figure Global Type 2 Diabetes Therapeutics Production Market Share by Region ( 2016 - 2021)
Figure 2020 Global Type 2 Diabetes Therapeutics Production Market Share by Region
Table Global Type 2 Diabetes Therapeutics Revenue (Million USD) by Region ( 2016 - 2021)
Table Global Type 2 Diabetes Therapeutics Revenue Market Share by Region ( 2016 - 2021)
Figure Global Type 2 Diabetes Therapeutics Revenue Market Share by Region ( 2016 - 2021)
Table 2020 Global Type 2 Diabetes Therapeutics Revenue Market Share by Region
Figure Global Type 2 Diabetes Therapeutics Capacity, Production (K Units) and Growth Rate ( 2016 - 2021)
Table Global Type 2 Diabetes Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ( 2016 - 2021)
Table North America Type 2 Diabetes Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ( 2016 - 2021)
Table Europe Type 2 Diabetes Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ( 2016 - 2021)
Table China Type 2 Diabetes Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ( 2016 - 2021)
Table Japan Type 2 Diabetes Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ( 2016 - 2021)
Table Southeast Asia Type 2 Diabetes Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ( 2016 - 2021)
Table India Type 2 Diabetes Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ( 2016 - 2021)
